Aclaris Gets FDA Nod to Begin Phase 1a/1b Trial of...
Category : Clinical Trial Update 24 April 2025Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel p...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Invivoscribe’s FLT3 ITD MRD Assay Approved by NY S...
Category : Approval/Launch 24 April 2025Invivoscribe, a global and vertically integrated biotechnology company dedicated to improving human...
Gene Solutions and Element Biosciences Collaborati...
Category : Licensing/Collaboration Deal 24 April 2025Gene Solutions has announced a strategic collaboration with Element Biosciences. The partne...
Zealand Pharma Begins Phase 2b ZUPREME-2 Trial for...
Category : Clinical Trial Update 24 April 2025Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in p...
China NMPA Approves Rona’s IND for RN1871 siRNA Dr...
Category : Approval/Launch 23 April 2025Rona Therapeutics, a biotechnology company pioneering innovative RNA-targeted therapies, announced t...
Latest Newsletter Post
-
Zealand Pharma Begins Phase 2b ZUPR..
24 April 2025
-
Gene Solutions and Element Bioscien..
24 April 2025
-
Invivoscribe’s FLT3 ITD MRD Assay A..
24 April 2025
-
Aclaris Gets FDA Nod to Begin Phase..
24 April 2025
-
Roche Gets CE Mark for Chest Pain A..
23 April 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com